AtkinsRéalis Group (ATRL) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Achieved strong Q3 2024 results with enhanced margins, robust operating cash flows, and record Nuclear backlog, driven by sustained demand for engineering services and margin improvement focus.
Revenues, backlog, and margins improved, supported by operational efficiencies, strategic focus, and global demand for sustainable infrastructure.
Nuclear business remains a distinct competitive advantage, with significant life extension contracts and global opportunities.
Headcount increased by approximately 1,600 net additions year-to-date.
Financial highlights
Total Q3 revenue increased 11% year-over-year to $2.45B, with AtkinsRéalis Services revenue up 15% to $2.3B and organic growth at 13.5%.
Segment-adjusted EBIT rose 25% to $246M; adjusted EPS from PS&PM was $0.63, up 66% year-over-year.
Free cash flow for Q3 was $226M; net cash from operations reached $267M.
Net income attributable to shareholders was $103.7M ($0.59/diluted share), compared to $105.0M ($0.60/diluted share) in Q3 2023, which included a $46.2M gain on a business disposal.
Backlog at quarter-end was $16.8B, up 35% year-over-year; Nuclear backlog hit a record $3.2B, up over 200%.
Outlook and guidance
Maintains 8%-10% full-year revenue growth outlook for Engineering Services Regions and targets >8% annual organic growth through 2027.
Nuclear organic revenue growth targeted at 30%-35% for 2024; annual revenue of $1.8B-$2.0B by 2027.
Margin improvement journey continues, targeting 17%-18% engineering services margin and 12%-14% nuclear margin by 2027.
Expects net cash from operations to exceed $400M for the full year.
Q4 organic growth expected to be relatively flat due to project closeouts and strong prior-year comparison.
Latest events from AtkinsRéalis Group
- Record revenue, earnings, and backlog in 2025 set the stage for continued growth in 2026.ATRL
Q4 202527 Feb 2026 - Targeting >8% organic growth, margin expansion, and nuclear leadership with disciplined capital allocation.ATRL
Investor Day 20243 Feb 2026 - Record backlog, double-digit growth, and upgraded nuclear outlook highlight Q2 2024.ATRL
Q2 20241 Feb 2026 - Record 2024 revenue, backlog, and $2.8B asset sale set up growth and margin gains for 2025.ATRL
Q4 20242 Dec 2025 - Q2 2025 saw record backlog, 15% revenue growth, and a $2.32B net income surge.ATRL
Q2 202523 Nov 2025 - Record backlog and surging Nuclear growth drive raised outlook and strong Q1 2025 results.ATRL
Q1 202519 Nov 2025 - Q3 2025 saw double-digit revenue and EPS growth, record backlog, and raised Nuclear guidance.ATRL
Q3 202513 Nov 2025